Rotation Medical, based in Minnesota, is dedicated to combating rotator cuff disease by developing and providing innovative collagen scaffolds. The company, originally operating as Denali Medical Inc., underwent a rebranding in March 2010. Established in 2009, Rotation Medical has garnered significant attention in the biotechnology and healthcare sectors. With its last investment of $12.00M in a Series B funding round on 16 August 2016, the company has attracted support from prominent investors such as New Enterprise Associates, Life Science Partners, and Pappas Ventures. This strategic financing is expected to propel Rotation Medical's groundbreaking solutions.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $12.00M | 3 | EQT Life Sciences | 16 Aug 2016 |
Series B | $27.20M | 3 | EQT Life Sciences | 02 Jul 2014 |
Debt Financing | $5.50M | - | 05 Jun 2013 | |
Venture Round | $10.00M | - | 14 Apr 2011 | |
Venture Round | $3.88M | - | 18 Mar 2010 |
No recent news or press coverage available for Rotation Medical.